MediPal Holdings Dirección

Dirección controles de criterios 2/4

El CEO de MediPal Holdings' es Shuichi Watanabe, nombrado en Apr 2012, tiene una permanencia de 24.25 años. posee directamente un 0.082% de las acciones de la empresa, con un valor de €2.53M. La antigüedad media del equipo directivo y de la junta directiva es de 11.6 años y 7.3 años, respectivamente.

Información clave

Shuichi Watanabe

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	12yrs
Participación del CEO	0.08%
Permanencia media de la dirección	11.6yrs
Promedio de permanencia en la Junta Directiva	7.3yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Shuichi Watanabe (71 yo)

12yrs

Permanencia

Mr. Shuichi Watanabe has been Chief Compliance Officer of MediPal Holdings Corporation since June 25, 2020. Mr. Watanabe has been Chief Executive Officer and President at MediPal Holdings Corporation since...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Shuichi Watanabe	Chief Compliance Officer	12yrs	sin datos	0.082% ¥ 2.5m
Yuji Sakon	MD, GM of Administration Division & Director	11.3yrs	sin datos	sin datos
Toshihide Yoda	Senior MD of Investor Relations	12.3yrs	sin datos	0.0057% ¥ 175.9k
Yasuhiro Choufuku	Executive VP & Director	7.8yrs	sin datos	0.024% ¥ 748.1k
Shinjiro Watanabe	GM of Information Systems Management Division & Director	no data	sin datos	0.016% ¥ 484.1k

11.6yrs

Permanencia media

69yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 59Z es experimentado (11.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Shuichi Watanabe	Chief Compliance Officer	24.3yrs	sin datos	0.082% ¥ 2.5m
Yuji Sakon	MD, GM of Administration Division & Director	12.3yrs	sin datos	sin datos
Toshihide Yoda	Senior MD of Investor Relations	14.3yrs	sin datos	0.0057% ¥ 175.9k
Yasuhiro Choufuku	Executive VP & Director	5.3yrs	sin datos	0.024% ¥ 748.1k
Shinjiro Watanabe	GM of Information Systems Management Division & Director	11.3yrs	sin datos	0.016% ¥ 484.1k
Yoko Sanuki	Outside Audit & Supervisory Board Member	no data	sin datos	sin datos
Kuniko Shoji	Independent Outside Director	6.3yrs	sin datos	sin datos
Toshio Asano	Independent Outside Director	7.3yrs	sin datos	0.0029% ¥ 88.1k
Hiroshi Iwamoto	Independent Outside Director	3.3yrs	sin datos	sin datos
Koichi Mimura	Director	4.3yrs	sin datos	0.00048% ¥ 14.8k
Mitsuko Kagami	Independent Outside Director	10.3yrs	sin datos	sin datos
Seiichi Kasutani	Director	5.3yrs	sin datos	sin datos

7.3yrs

Permanencia media

69yo

Promedio de edad

Junta con experiencia: La junta directiva de 59Z se considera experimentada (7.3 años de antigüedad promedio).

MediPal Holdings Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

MediPal Holdings Corporation, Annual General Meeting, Jun 27, 2023

Less than half of directors are independent

MediPal Holdings Corporation, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Recent updates

MediPal Holdings Corporation (TSE:7459) agreed to acquire PreMedica Inc. from Noritsu Koki Co., Ltd. (TSE:7744) for ¥3.8 billion.

Upcoming dividend of JP¥30.00 per share

MediPal Holdings Corporation to Report Fiscal Year 2024 Results on May 14, 2024

Third quarter 2024 earnings released: EPS: JP¥52.80 (vs JP¥59.65 in 3Q 2023)

MediPal Holdings Corporation to Report Q3, 2024 Results on Feb 05, 2024

Second quarter 2024 earnings released: EPS: JP¥28.08 (vs JP¥43.12 in 2Q 2023)

Upcoming dividend of JP¥30.00 per share at 2.3% yield

MediPal Holdings Corporation to Report Q2, 2024 Results on Nov 02, 2023

First quarter 2024 earnings released: EPS: JP¥52.32 (vs JP¥39.39 in 1Q 2023)

MediPal Holdings Corporation to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings released: EPS: JP¥185 (vs JP¥140 in FY 2022)

MediPal Holdings Corporation, Annual General Meeting, Jun 27, 2023

Upcoming dividend of JP¥23.00 per share at 2.6% yield

Third quarter 2023 earnings released: EPS: JP¥59.65 (vs JP¥49.09 in 3Q 2022)

MediPal Holdings Corporation (TSE:7459) entered into a Share Purchase agreement to acquire Sumitomo Pharma FOOD & CHEMICAL Co., LTD. from Sumitomo Pharma Co., Ltd. (TSE:4506).

MediPal Holdings Corporation to Report Q3, 2023 Results on Feb 01, 2023

Second quarter 2023 earnings released: EPS: JP¥43.12 (vs JP¥43.25 in 2Q 2022)

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥43.12 (vs JP¥43.25 in 2Q 2022)

Upcoming dividend of JP¥23.00 per share

MediPal Holdings Corporation to Report Q2, 2023 Results on Oct 31, 2022

First quarter 2023 earnings released: EPS: JP¥39.39 (vs JP¥44.98 in 1Q 2022)

MediPal Holdings Corporation to Report Q1, 2023 Results on Jul 29, 2022

Full year 2022 earnings released: EPS: JP¥140 (vs JP¥114 in FY 2021)

MediPal Holdings Corporation, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Upcoming dividend of JP¥21.00 per share

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Now 21% undervalued

Second quarter 2022 earnings released: EPS JP¥43.25 (vs JP¥23.93 in 2Q 2021)

Upcoming dividend of JP¥21.00 per share

First quarter 2022 earnings released: EPS JP¥44.98 (vs JP¥32.88 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥114 (vs JP¥176 in FY 2020)

Upcoming dividend of JP¥21.00 per share

MediPal Holdings Corporation to Report Fiscal Year 2021 Results on May 13, 2021

Third quarter 2021 earnings released: EPS JP¥21.05 (vs JP¥52.72 in 3Q 2020)

Revenue beats expectations

New 90-day high: €16.92

New 90-day high: €16.80

MediPal Holdings Corporation to Report Q3, 2021 Results on Jan 29, 2021

Second quarter 2021 earnings released: EPS JP¥23.93

Revenue misses expectations

First half earnings released

Semi-annual earnings released: Revenue misses expectations

New 90-day low: €15.20

MediPal Holdings Corporation to Report Q2, 2021 Results on Oct 30, 2020

First quarter earnings released

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad